Koestler Thomas P 4

4 · MOMENTA PHARMACEUTICALS INC · Filed Jun 25, 2018

Form 4

Period: 2018-06-20

Director

Transactions

Exercise/Conversion
Restricted Stock Units
2018-06-20−5,734→ 0 total
→ Common Stock (5,734 underlying)
Exercise/Conversion
Common Stock
2018-06-20+5,734→ 11,234 total
Award
Stock Option (Right to Buy)
2018-06-20+8,855→ 8,855 total
Exercise: $22.30Exp: 2028-06-20→ Common Stock (8,855 underlying)
Award
Restricted Stock Units
2018-06-20+4,356→ 4,356 total
→ Common Stock (4,356 underlying)

Footnotes (5)

[F1]Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan. The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Koestler's continued service to the Company.
[F2]Each restricted stock unit represents a contingent right to receive one share of MNTA common stock.
[F3]Represents 4,356 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Koestler's continued service to the Company.
[F4]Restricted Stock Units convert into common stock on a one-for-one basis.
[F5]Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date.

Documents

2 files